Functional dissection of the HNF-1alpha transcription factor: A study on nuclear localization and transcriptional activation

被引:22
作者
Bjorkhaug, L
Bratland, A
Njolstad, PR [1 ]
Molven, A
机构
[1] Univ Bergen, Dept Clin Med, Paediat Sect, N-5020 Bergen, Norway
[2] Univ Bergen, Sect Med Genet & Mol Med, N-5020 Bergen, Norway
[3] Haukeland Hosp, Dept Paediat, Bergen, Norway
[4] Univ Bergen, Gade Inst, Sect Pathol, N-5020 Bergen, Norway
关键词
D O I
10.1089/dna.2005.24.661
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte nuclear factor-1alpha (HNF-1alpha) is a homeodomain-containing transcription factor regulating the expression of liver and pancreas-specific genes. Mutations in the HNF-1alpha-encoding gene TCF1 cause maturity-onset diabetes of the young, type 3 (MODY3). These mutations may affect nuclear import or reduce the ability of HNF-1alpha to stimulate transcription. We performed a functional dissection of HNF-1alpha, attempting both to define its nuclear localization signals (NLSs) and to identify important elements of the C-terminal transactivation domain. Three HNF-1alpha regions, A ( amino acids 158 - 171), B ( 197 - 205), and C ( 271 - 282), highly similar to consensus NLSs, were studied by immunolocalization in HeLa cells. Region B could be identified as the most critical for correct nuclear localization. Deletion of two subregions ( amino acids 398 - 470 and 544 - 631, respectively) in the HNF-1alpha C-terminal transactivation domain, resulted in the greatest reduction in stimulation of transcription compared to wild-type protein. However, this domain probably consists of many elements that work in concert to give the full transactivation potential of the protein.
引用
收藏
页码:661 / 669
页数:9
相关论文
共 37 条
[1]   Hepatocyte nuclear factor-1α recruits the transcriptional co-activator p300 on the GLUT2 gene promoter [J].
Ban, N ;
Yamada, Y ;
Someya, Y ;
Miyawaki, K ;
Ihara, Y ;
Hosokawa, M ;
Toyokuni, S ;
Tsuda, K ;
Seino, Y .
DIABETES, 2002, 51 (05) :1409-1418
[2]   Hepatocyte nuclear factor-1α gene mutations and diabetes in Norway [J].
Bjorkhaug, L ;
Sagen, JV ;
Thorsby, P ;
Sovik, O ;
Molven, A ;
Njolstad, PR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) :920-931
[3]   MODY associated with two novel hepatocyte nuclear factor-1α loss-of-function mutations (P112L and Q466X) [J].
Bjorkhaug, L ;
Ye, HG ;
Horikawa, Y ;
Sovik, O ;
Molven, A ;
Njolstad, PR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (03) :792-798
[4]   A transcription factor regulatory circuit in differentiated pancreatic cells [J].
Boj, SF ;
Párrizas, M ;
Maestro, MA ;
Ferrer, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) :14481-14486
[5]   PUTATIVE NUCLEAR-LOCALIZATION SIGNALS (NLS) IN PROTEIN TRANSCRIPTION FACTORS [J].
BOULIKAS, T .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 55 (01) :32-58
[6]   To be or not to be in the nucleolus [J].
Carmo-Fonseca, M ;
Mendes-Soares, L ;
Campos, I .
NATURE CELL BIOLOGY, 2000, 2 (06) :E107-E112
[7]  
CARRIERE C, 1995, CELL GROWTH DIFFER, V6, P1531
[8]   Liver-enriched transcription factors and hepatocyte differentiation [J].
Cereghini, S .
FASEB JOURNAL, 1996, 10 (02) :267-282
[9]   Diabetes mutations delineate an atypical POU domain in HNF-1α [J].
Chi, YI ;
Frantz, JD ;
Oh, BC ;
Hansen, L ;
Dhe-Paganon, S ;
Shoelson, SE .
MOLECULAR CELL, 2002, 10 (05) :1129-1137
[10]   NUCLEAR TARGETING SEQUENCES - A CONSENSUS [J].
DINGWALL, C ;
LASKEY, RA .
TRENDS IN BIOCHEMICAL SCIENCES, 1991, 16 (12) :478-481